We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- COVID-19 (127)
- COVID-19 vaccines (80)
- Advertising (77)
- Prescription medicines (33)
- Regulatory compliance (19)
- Alert/Advisory (15)
- Medicines safety (15)
- Safety (7)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Manufacturing (6)
- Disinfectants/Sterilants (5)
- Labelling and packaging (3)
- Over the counter (OTC) medicines (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Shortages (2)
- Cosmetics (1)
- Import and export (1)
- Listed medicines (1)
- Medicinal cannabis hub (1)
- Non-prescription medicines (1)
- Scheduling (national classification system) (1)
Results for
"[search-keyword]"
Collection content
308 result(s) found, displaying 191 to 200
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NewsUpdated storage conditions for the Pfizer COVID-19 vaccine
-
NewsThe TGA granted a provisional determination to GlaxoSmithKline Australia Pty Ltd in relation to the monoclonal antibody treatment, SOTROVIMAB (GSK4182136) on 14 April 2021
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
NewsThe granting of this determination means that Pfizer is now eligible to apply to vary its provisional registration for the vaccine for use in individuals 12 years of age or older.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Safety alertsThree additional Australian cases of TTS likely linked to AstraZeneca ChAdOx1-S COVID-19 vaccine